S&P/TSX Composite Index Ends 0.73% Lower at 21740.20 — Data Talk
The S&P/TSX Composite Index is down 159.79 points or 0.73% today to 21740.20
--Down for four consecutive trading days
--Down 621.58 points or 2.78% over the last four trading days
--Largest four-day point and percentage decline since Monday, Oct. 23, 2023
--Longest losing streak since Friday, Oct. 27, 2023, when the market fell for eight straight trading days
--Down five of the past six trading days
--Off 2.78% from its record close of 22361.78 hit Tuesday, April 9, 2024
--Lowest closing value since Friday, March 8, 2024
--Off 2.78% from its 52-week high of 22361.78 hit Tuesday, April 9, 2024
--Up 16.03% from its 52-week low of 18737.39 hit Friday, Oct. 27, 2023
--Rose 5.32% from 52 weeks ago
--Off 2.78% from its 2024 closing high of 22361.78 hit Tuesday, April 9, 2024
--Up 5.61% from its 2024 closing low of 20584.97 hit Tuesday, Feb. 13, 2024
--Month-to-date it is down 1.93%
--Year-to-date it is up 781.76 points or 3.73%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 15, 2024 17:25 ET (21:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year